Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Cash from Operations (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Cash from Operations for 5 consecutive years, with 11024000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 22.65% to 11024000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 60292000.0 through Dec 2025, down 7.3% year-over-year, with the annual reading at 60292000.0 for FY2025, 7.3% down from the prior year.
  • Cash from Operations for Q4 2025 was 11024000.0 at Werewolf Therapeutics, up from 15156000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 303000.0 in Q2 2022, with the low at 18948000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 11628200.0, with a median of 12439500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations skyrocketed 97.1% in 2022, then crashed 3504.29% in 2023.
  • Over 5 years, Cash from Operations stood at 12673000.0 in 2021, then rose by 6.34% to 11870000.0 in 2022, then skyrocketed by 61.37% to 4585000.0 in 2023, then tumbled by 210.84% to 14252000.0 in 2024, then grew by 22.65% to 11024000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 11024000.0, 15156000.0, and 15164000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.